The Alliance for Benzodiazepine Best Practices (EIN 824973519) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2018

Legal Domicile

Principal Officer

Bernard Silvernail

Phone

5037048983

Tax Period

2024-01-01 to 2024-12-31

The Alliance for Benzodiazepine Best Practices, founded in 2018, is a small nonprofit in the Medical Research sector that reported $133K in total revenue in fiscal year 2024. Revenue surged 21% from the prior year, signaling strong growth momentum. The organization ran a surplus of $38K, a strong 29% operating margin.

Mission

Our mission is to reduce the harm caused by benzodiazepines and Z-drugs by making evidence-based improvements to the prescribing of these medications.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $94,935

Program Service Revenue $35,878

Investment Income $1,724

Other Revenue $0

TOTAL REVENUE $132,537

Expense Breakdown

Grants Paid $0

Salaries & Benefits $19,959

Fundraising Expenses $3,851

Program Expenses $79,237

Other Expenses $71,274

TOTAL EXPENSES $94,312

Year-over-Year Comparison

	2024	2023	Change
Revenue	$132,537	$109,326	+0.2%
Expenses	$94,312	$77,556	+0.2%
Net Income	$38,225	$31,770	+0.2%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Bernard Silvernail	President, Director	040.00	Officer Director	$0	$0	$0
Richard Bailey	Treasurer, Director	001.00	Officer Director	$0	$0	$0
Lori Mor	Director	001.00	Director	$0	$0	$0
Cathal Cadogon	Director	001.00	Director	$0	$0	$0
Christopher Blazes	Director	001.00	Director	$0	$0	$0
Jolene Bressi	Director	004.00	Director	$0	$0	$0
Judd Katz	Director	001.00	Director	$0	$0	$0
Alexis Ritvo	Medical Director	003.00	Director	$0	$0	$0
Jaden Brandt	Director	004.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	$132,537	$94,312	$97,016	$38,225
2023	$109,326	$77,556	$61,781	$31,770

The Alliance for Benzodiazepine Best Practices